Search

Additional file 2. Patient Information and Consent Form. Description. The Patient Information and Consent Form used to obtain patient consent to participate in the study.

Additional file 4. Transdisciplinary Initial Neurological Screening Assessment (TINSA)© 2022 Mater Misericordiae Limited ABN 83906708922. Description. A copy of the novel TINSA developed at the Mater Hospial Brisbane Acute Stroke Unit. The study protocol describes how the novel TINSA is being evaluated, compared to usual allied health assessment.

Additional file 1. SPIRIT Checklist. Description. Completed SPIRIT Checklist.

Additional file 8. Staff Confidence Survey. Description. Data collection form used to obtain staff confidence data over time.

Additional file 6. Staff Satisfaction Survey. Description. Data collection form used to obtain staff satisfaction data.

Additional file 7. Interprofessional Staff Trust Survey. Description. The fit-for-purpose data collection form (i.e., not the validated team trust survey) used to obtain interprofessional staff trust data.

Additional file 3. Healthcare Information and Consent Form. Description. The Patient Information and Consent Form used to obtain patient consent to participate in the study.

A review In early 2020, coronavirus disease 2019 (COVID-19) occupies the public health vanguard for all governments across the world In China, where the virus was first identified and where to date the greatest numbers of infected people are located, significant efforts are being made to address the public health threat posed by the disease, and to identify methods to treat the disease One method being used is ultra-shortwave diathermy (USWD) This paper reviews relevant aspects of this form of electromagnetic energy to elucidate its risks and any potential benefits in acute infective conditions of the lung When managing patients with COVID-19, the hazards to staff and patients of cross contamination by equipment and the risks of unintentional viral spread must first be considered Further, in any application of electrotherapy modality to a patient, procedures involving assessment of reliability of machine output and normal skin sensation of the patient must be ascertained In patients with COVID-19, the risk of passing a current close to the heart must be considered A review of evidence on the uses of reduction of such content in physiotherapy entry-level curricula There is no evidence of a clin benefit of USWD in China, there is a lack of reports that describe proper randomization methods, consideration of electrode placements, and essential safety measure procedures The long-term effect on lung function should be contemplated In conclusion, the authors highlight the need for structured gathering of data to investigate the role of USWD on acute and chronic effect on lung lesion prior to endorsing an unconstrained application of USWD to patients with COVID-19

Additional file 1: Supplementary Table 1. Parameters of the photobiomodulation devices and treatment used in the study. Supplementary Table 2. Mean (st dev) of measures of fine motor control, mobility, balance and cognition before PBM treatment in a second study of PD treatment with PBM. Supplementary Table 3. Individual data for participants before and after treatment with the photobiomodulation protocols.